By Dietrich Knauth (Reuters) – A federal judge has ordered 3M Co CEO Michael Roman to attend mediation aimed at resolving nearly 260,000 lawsuits alleging that 3M military earplugs caused hearin[...]
Read more
Health
Walmart forays into telehealth for pets with Pawp tie-up
(Reuters) – Walmart Inc said on Monday it has signed a deal with pet telehealth provider Pawp to offer the retailer’s subscribed members access to veterinary professionals via video or tex[...]
Read more
Ironwood bulks up on digestive therapies with $1.15 billion VectivBio buy
By Raghav Mahobe (Reuters) -Ironwood Pharmaceuticals Inc said on Monday it would buy Switzerland-based drug developer VectivBio Holding AG for $1.15 billion, adding a promising treatment for digestive[...]
Read more
Walgreens fights ‘staggering’ $642 million arbitration award to Humana
By Mike Scarcella (Reuters) – National retail pharmacy giant Walgreen Co has asked a U.S. judge to vacate an arbitrator’s award of more than $642 million to Humana Health Plan Inc in a dru[...]
Read more
CureVac files expanded patent lawsuit against Pfizer/BioNTech over mRNA technology
(Reuters) – CureVac NV said on Friday it had filed an expanded patent infringement claim against Pfizer Inc and BioNTech over the use of mRNA technology and that a U.S. court had granted its req[...]
Read more
Amgen agrees not to seek quick close to Horizon acquisition
WASHINGTON (Reuters) – Amgen Inc has agreed not to quickly close on its $27.8 billion acquisition of Horizon Therapeutics after the U.S. Federal Trade Commission (FTC) filed suit to block the de[...]
Read more
Catalent cuts forecast, delays results again as challenges mount
By Bhanvi Satija and Pratik Jain (Reuters) -Contract drug manufacturer Catalent Inc on Friday slashed its full-year forecasts for profit and sales and delayed its quarterly results for the third time,[...]
Read more
FTC effort to stop Amgen’s Horizon takeover faces uphill fight
By Diane Bartz WASHINGTON (Reuters) – The Federal Trade Commission (FTC) faces an uphill battle in its fight against Amgen Inc’s $27.8 billion acquisition of Horizon Therapeutics with an u[...]
Read more
AstraZeneca’s China boss says drugmaker will seek to “love the Communist Party”
By Joe Cash and Brenda Goh BEIJING (Reuters) – Global drugmaker AstraZeneca will seek to be a patriotic company in China that “loves the Communist Party”, its China president said at[...]
Read more